ITCI stock forecast for 2023 – 2027
Last updated: April 25, 2024
Are you interested in Intra-Cellular Therapies, Inc. stocks prediction? If yes, then on this page you will find useful information about the dynamics of the ITCI stock price in 2022-2027. Is ITCI a good long term stock? When should I take profit in Intra-Cellular Therapies stock? Buy or sell stock? Will ITCI stock price go up? What are analysts’ forecasts for ITCI stock?
Forecst.com predicts future values using technical analysis of a large number of analytical parameters. ITCI stock returns are also predicted based on historical data.
According to our research, ITCI stock is a good long-term investment. ITCI share price has been in a positive cycle for the past year. Intra-Cellular Therapies, Inc. stock trend is positive.
Intra-Cellular Therapies company info
| Industry | Drug Manufacturers—Specialty & Generic |
| Address | 430 East 29th Street, New York, NY, 10016, United States |
| Website | https://www.intracellulartherapies.com |
Forecasting
52 Week High: 61.5575 USD
52 Week Low: 45.5788 USD
1 Year Forecast: 59.2079 USD
5 Year Forecast: 102.939 USD
Agilent Technologies info
Market Cap: 3.91B
52 Week Change: 14.132%
52 Week High: 55.2 USD
52 Week Low: 28.4 USD
Beta: 0.650904
50 Day Moving Average: 44.5
90 Day Moving Average: 43.135
200 Day Moving Average: 38.94
Resistance Level: 50.7121
Pivot Point: 46.3419
Support Level: 44.09
Enterprise Value: 0
Forward P/E: 0
Forward EPS: 0
Profit Margin: 0
Shares Outstanding: 0
EBITDA: 0
Held Percent Institutions: 0
PEG Ratio (5Y): 0
Trailing EPS: 0
Intra-Cellular Therapies stock forecasts for 2023-2027
| Date | Open Price | Close Price | Change |
Intra-Cellular Therapies Stock Forecast for 2023 | |||
| January 2023 | 60 | 57.42 | -4.3% |
| February 2023 | 59.16 | 60.18 | 1.72% |
| March 2023 | 60.18 | 56.84 | -5.55% |
| April 2023 | 57.42 | 57.82 | 0.7% |
| May 2023 | 58.41 | 63 | 7.86% |
| June 2023 | 63.63 | 65 | 2.15% |
| July 2023 | 63.7 | 64.26 | 0.88% |
| August 2023 | 62.37 | 63 | 1.01% |
| September 2023 | 63.36 | 64.68 | 2.08% |
| October 2023 | 63.7 | 64.68 | 1.54% |
| November 2023 | 66.66 | 66.66 | 0% |
| December 2023 | 66 | 70.29 | 6.5% |
Intra-Cellular Therapies Stock Forecast for 2024 | |||
| January 2024 | 71.28 | 68.31 | -4.17% |
| February 2024 | 70.38 | 70.7 | 0.45% |
| March 2024 | 70.7 | 70.7 | 0% |
| April 2024 | 70.7 | 70 | -0.99% |
| May 2024 | 70 | 73.26 | 4.66% |
| June 2024 | 73.26 | 77.52 | 5.81% |
| July 2024 | 76 | 75.75 | -0.33% |
| August 2024 | 76.5 | 75 | -1.96% |
| September 2024 | 76.76 | 77 | 0.31% |
| October 2024 | 77 | 77.22 | 0.29% |
| November 2024 | 78.54 | 77.77 | -0.98% |
| December 2024 | 78.78 | 81.34 | 3.25% |
Intra-Cellular Therapies Stock Forecast for 2025 | |||
| January 2025 | 81.34 | 80 | -1.65% |
| February 2025 | 81 | 82.82 | 2.25% |
| March 2025 | 82 | 80.19 | -2.21% |
| April 2025 | 82.62 | 83.64 | 1.23% |
| May 2025 | 81.18 | 83.3 | 2.61% |
| June 2025 | 84.28 | 86.24 | 2.33% |
| July 2025 | 86.24 | 85.14 | -1.28% |
| August 2025 | 87.72 | 86 | -1.96% |
| September 2025 | 85.26 | 90.78 | 6.47% |
| October 2025 | 88.11 | 87.22 | -1.01% |
| November 2025 | 89 | 87.22 | -2% |
| December 2025 | 89 | 95.95 | 7.81% |
Intra-Cellular Therapies Stock Forecast for 2026 | |||
| January 2026 | 96.9 | 90.16 | -6.96% |
| February 2026 | 92 | 91.14 | -0.93% |
| March 2026 | 93 | 92.07 | -1% |
| April 2026 | 92.07 | 93.93 | 2.02% |
| May 2026 | 93.93 | 98.94 | 5.33% |
| June 2026 | 97.97 | 100.98 | 3.07% |
| July 2026 | 99.99 | 98 | -1.99% |
| August 2026 | 98 | 96.04 | -2% |
| September 2026 | 96.04 | 101 | 5.16% |
| October 2026 | 101 | 99 | -1.98% |
| November 2026 | 99.99 | 102.01 | 2.02% |
| December 2026 | 101 | 106 | 4.95% |
Intra-Cellular Therapies Stock Forecast for 2027 | |||
| January 2027 | 106 | 100.94 | -4.77% |